Skip to main content
. Author manuscript; available in PMC: 2021 Sep 27.
Published in final edited form as: J Med Genet. 2019 Nov 29;57(5):331–338. doi: 10.1136/jmedgenet-2019-106283

Table 2.

Average % Difference in Variant Dosage

Sample Size Average % Difference in GRS (CI 95%) Significant Iterations Average % Difference in GRS (CI 95%) All Iterations % Difference Range (Min – Max)
200 41.60 (40.57 – 42.62) 51.55 (49.01 – 54.10) 0.079 – 198.76
400 33.80 (32.68 – 34.93) 36.60 (34.77 – 38.42) 0.045 – 179.82
600 91.31 (85.58 – 97.05) 29.14 (27.67 – 30.61) 0.024 – 146.82
1000 71.15 (66.91 – 75.39) 22.64 (21.52 – 23.77) 0.006 – 103.84
2000 48.03 (45.66 – 50.40) 16.67 (15.86 – 17.48) 0.006 – 86.71
3000 39.00 (37.45 – 40.56) 13.91 (13.25 – 14.56) 0.001 – 56.55
4000 35.02 (33.20 – 36.84) 11.22 (10.69 – 11.75) 0.016 – 53.26
5000 29.87 (28.43 – 31.31) 10.58 (10.09 – 11.07) 0.014 – 47.12

The average percent difference in allele dosage for each of the 47 variants used in this study between trial arms and related confidence intervals are shown for each sample size for both significant and total iteration. Significant iterations were determined by Z-score cut-off scores of ± 1.96 (p < 0.05). Minimum and maximum percent differences found between arms are also shown.